Related Experiment Video
Updated: Nov 15, 2025

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
Published on: November 30, 2022
Treating COVID-19 Acute Severe Hypoxemic Respiratory Failure: First Case Report Utilizing Dexamethasone, Remdesivir,
Richard L Gibson1, Zachary J Sletten2, Simon A Sarkisian3
1Department of Family Medicine, Thomas Moore Health Clinic, Fort Hood, TX.
Insights
This study details the first COVID-19 case managed in a deployed, resource-limited setting. The patient received dexamethasone, remdesivir, convalescent plasma, ventilation, and proning, highlighting novel treatment strategies.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Military Medicine
Background:
- The global COVID-19 pandemic has overwhelmed healthcare systems worldwide.
- Resource-limited and austere environments present unique challenges for managing infectious diseases.
- Effective treatment protocols are crucial for improving patient outcomes during pandemics.
Observation:
- A case of COVID-19 was managed in the austere deployed environment of Operation Inherent Resolve.
- The patient received a combination of dexamethasone, remdesivir, and COVID-19 convalescent plasma.
- Positive pressure ventilation and proning were utilized as supportive care measures.
Findings:
- Successful management of a severe COVID-19 case in a resource-constrained setting was achieved.
- Multimodal treatment approach including antivirals, immunomodulators, and supportive care demonstrated efficacy.
- The case highlights the adaptability of healthcare teams in challenging operational environments.
Implications:
- This case provides valuable insights into managing COVID-19 in austere and deployed settings.
- Findings can inform the development of clinical guidelines for resource-limited healthcare scenarios.
- Successful management strategies can be adapted for future public health emergencies in deployed forces.
Abstract:
Coronavirus 2019 (COVID-19) has spread across the globe with a concerningly high infectivity resulting in the World Health Organization deeming it a pandemic. It has resulted in thousands of deaths and placed enormous strain on communities, healthcare systems and healthcare workers as they battle shortages of ventilators, supplies, and difficulties in protecting patients and hospital staff alike. Challenges in managing the disease have led to new treatment and management strategies as healthcare teams struggle to adapt. We present the first case of COVID-19 managed in the austere deployed environment of Operation Inherent Resolve in which the patient was treated with dexamethasone, remdesivir, COVID-19 convalescent plasma, positive pressure ventilation, and proning. We discuss some of the inherent and unique challenges of caring for a patient in this resource constrained environment with a brief review of the literature on the treatment and management.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-IV
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...